Selected research
Market Outlook & Growth Opportunities
Global Laboratory-Developed Testing Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Laboratory-Developed Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Laboratory-Developed Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Laboratory-Developed Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Laboratory-Developed Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Laboratory-Developed Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Laboratory-Developed Testing Service market include Quest Diagnostics, Thermo Fisher, Waters Corporation, Roche, Illumina, Qiagen, Eurofins, Guardant Health and Adaptive Biotechnologies, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Laboratory-Developed Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Laboratory-Developed Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Laboratory-Developed Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Laboratory-Developed Testing Service market.
Laboratory-Developed Testing Service Segment by Company
Quest Diagnostics
Thermo Fisher
Waters Corporation
Roche
Illumina
Qiagen
Eurofins
Guardant Health
Adaptive Biotechnologies
Biodesix
Berry Oncology
Genetron Health
SRL
BML
Laboratory-Developed Testing Service Segment by Type
Rapid Testing (24–48 Hours)
Standard Testing (3–7 Days)
In-depth Analysis (7–14+ Days)
Laboratory-Developed Testing Service Segment by Application
Hospitals Laboratory
Clinical Research Organizations
Academic Institutes
Specialty Diagnostic Centers
Others
Laboratory-Developed Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Laboratory-Developed Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Laboratory-Developed Testing Service key companies, revenue, market share, and recent developments.
3. To split the Laboratory-Developed Testing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Laboratory-Developed Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Laboratory-Developed Testing Service significant trends, drivers, influence factors in global and regions.
6. To analyze Laboratory-Developed Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laboratory-Developed Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Laboratory-Developed Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laboratory-Developed Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Laboratory-Developed Testing Service industry.
Chapter 3: Detailed analysis of Laboratory-Developed Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Laboratory-Developed Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Laboratory-Developed Testing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Rapid Testing (24–48 Hours)
- Standard Testing (3–7 Days)
- In-depth Analysis (7–14+ Days)
Applications
- Hospitals Laboratory
- Clinical Research Organizations
- Academic Institutes
- Specialty Diagnostic Centers
- Others
Companies covered
- Quest Diagnostics
- Thermo Fisher
- Waters Corporation
- Roche
- Illumina
- Qiagen
- Eurofins
- Guardant Health
- Adaptive Biotechnologies
- Biodesix
- Berry Oncology
- Genetron Health
- SRL
- BML
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Laboratory-Developed Testing Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Laboratory-Developed Testing Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Laboratory-Developed Testing Service Market Dynamics
- 2.1 Laboratory-Developed Testing Service Industry Trends
- 2.2 Laboratory-Developed Testing Service Industry Drivers
- 2.3 Laboratory-Developed Testing Service Industry Opportunities and Challenges
- 2.4 Laboratory-Developed Testing Service Industry Restraints
3 Laboratory-Developed Testing Service Market by Company
- 3.1 Global Laboratory-Developed Testing Service Company Revenue Ranking in 2025
- 3.2 Global Laboratory-Developed Testing Service Revenue by Company (2021-2026)
- 3.3 Global Laboratory-Developed Testing Service Company Ranking (2024-2026)
- 3.4 Global Laboratory-Developed Testing Service Company Manufacturing Base and Headquarters
- 3.5 Global Laboratory-Developed Testing Service Company Product Type and Application
- 3.6 Global Laboratory-Developed Testing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Laboratory-Developed Testing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Laboratory-Developed Testing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Laboratory-Developed Testing Service Market by Type
- 4.1 Laboratory-Developed Testing Service Type Introduction
- 4.1.1 Rapid Testing (24–48 Hours)
- 4.1.2 Standard Testing (3–7 Days)
- 4.1.3 In-depth Analysis (7–14+ Days)
- 4.2 Global Laboratory-Developed Testing Service Sales Value by Type
- 4.2.1 Global Laboratory-Developed Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Laboratory-Developed Testing Service Sales Value by Type (2021-2032)
- 4.2.3 Global Laboratory-Developed Testing Service Sales Value Share by Type (2021-2032)
5 Laboratory-Developed Testing Service Market by Application
- 5.1 Laboratory-Developed Testing Service Application Introduction
- 5.1.1 Hospitals Laboratory
- 5.1.2 Clinical Research Organizations
- 5.1.3 Academic Institutes
- 5.1.4 Specialty Diagnostic Centers
- 5.1.5 Others
- 5.2 Global Laboratory-Developed Testing Service Sales Value by Application
- 5.2.1 Global Laboratory-Developed Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Laboratory-Developed Testing Service Sales Value by Application (2021-2032)
- 5.2.3 Global Laboratory-Developed Testing Service Sales Value Share by Application (2021-2032)
6 Laboratory-Developed Testing Service Regional Value Analysis
- 6.1 Global Laboratory-Developed Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Laboratory-Developed Testing Service Sales Value by Region (2021-2032)
- 6.2.1 Global Laboratory-Developed Testing Service Sales Value by Region: 2021-2026
- 6.2.2 Global Laboratory-Developed Testing Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Laboratory-Developed Testing Service Sales Value (2021-2032)
- 6.3.2 North America Laboratory-Developed Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Laboratory-Developed Testing Service Sales Value (2021-2032)
- 6.4.2 Europe Laboratory-Developed Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Laboratory-Developed Testing Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Laboratory-Developed Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Laboratory-Developed Testing Service Sales Value (2021-2032)
- 6.6.2 South America Laboratory-Developed Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Laboratory-Developed Testing Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Laboratory-Developed Testing Service Sales Value Share by Country, 2025 VS 2032
7 Laboratory-Developed Testing Service Country-level Value Analysis
- 7.1 Global Laboratory-Developed Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Laboratory-Developed Testing Service Sales Value by Country (2021-2032)
- 7.2.1 Global Laboratory-Developed Testing Service Sales Value by Country (2021-2026)
- 7.2.2 Global Laboratory-Developed Testing Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Laboratory-Developed Testing Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Laboratory-Developed Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Laboratory-Developed Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Quest Diagnostics
- 8.1.1 Quest Diagnostics Company Information
- 8.1.2 Quest Diagnostics Business Overview
- 8.1.3 Quest Diagnostics Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Quest Diagnostics Laboratory-Developed Testing Service Product Portfolio
- 8.1.5 Quest Diagnostics Recent Developments
- 8.2 Thermo Fisher
- 8.2.1 Thermo Fisher Company Information
- 8.2.2 Thermo Fisher Business Overview
- 8.2.3 Thermo Fisher Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Laboratory-Developed Testing Service Product Portfolio
- 8.2.5 Thermo Fisher Recent Developments
- 8.3 Waters Corporation
- 8.3.1 Waters Corporation Company Information
- 8.3.2 Waters Corporation Business Overview
- 8.3.3 Waters Corporation Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Waters Corporation Laboratory-Developed Testing Service Product Portfolio
- 8.3.5 Waters Corporation Recent Developments
- 8.4 Roche
- 8.4.1 Roche Company Information
- 8.4.2 Roche Business Overview
- 8.4.3 Roche Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Roche Laboratory-Developed Testing Service Product Portfolio
- 8.4.5 Roche Recent Developments
- 8.5 Illumina
- 8.5.1 Illumina Company Information
- 8.5.2 Illumina Business Overview
- 8.5.3 Illumina Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Illumina Laboratory-Developed Testing Service Product Portfolio
- 8.5.5 Illumina Recent Developments
- 8.6 Qiagen
- 8.6.1 Qiagen Company Information
- 8.6.2 Qiagen Business Overview
- 8.6.3 Qiagen Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Qiagen Laboratory-Developed Testing Service Product Portfolio
- 8.6.5 Qiagen Recent Developments
- 8.7 Eurofins
- 8.7.1 Eurofins Company Information
- 8.7.2 Eurofins Business Overview
- 8.7.3 Eurofins Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Eurofins Laboratory-Developed Testing Service Product Portfolio
- 8.7.5 Eurofins Recent Developments
- 8.8 Guardant Health
- 8.8.1 Guardant Health Company Information
- 8.8.2 Guardant Health Business Overview
- 8.8.3 Guardant Health Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Guardant Health Laboratory-Developed Testing Service Product Portfolio
- 8.8.5 Guardant Health Recent Developments
- 8.9 Adaptive Biotechnologies
- 8.9.1 Adaptive Biotechnologies Company Information
- 8.9.2 Adaptive Biotechnologies Business Overview
- 8.9.3 Adaptive Biotechnologies Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Adaptive Biotechnologies Laboratory-Developed Testing Service Product Portfolio
- 8.9.5 Adaptive Biotechnologies Recent Developments
- 8.10 Biodesix
- 8.10.1 Biodesix Company Information
- 8.10.2 Biodesix Business Overview
- 8.10.3 Biodesix Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Biodesix Laboratory-Developed Testing Service Product Portfolio
- 8.10.5 Biodesix Recent Developments
- 8.11 Berry Oncology
- 8.11.1 Berry Oncology Company Information
- 8.11.2 Berry Oncology Business Overview
- 8.11.3 Berry Oncology Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Berry Oncology Laboratory-Developed Testing Service Product Portfolio
- 8.11.5 Berry Oncology Recent Developments
- 8.12 Genetron Health
- 8.12.1 Genetron Health Company Information
- 8.12.2 Genetron Health Business Overview
- 8.12.3 Genetron Health Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Genetron Health Laboratory-Developed Testing Service Product Portfolio
- 8.12.5 Genetron Health Recent Developments
- 8.13 SRL
- 8.13.1 SRL Company Information
- 8.13.2 SRL Business Overview
- 8.13.3 SRL Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
- 8.13.4 SRL Laboratory-Developed Testing Service Product Portfolio
- 8.13.5 SRL Recent Developments
- 8.14 BML
- 8.14.1 BML Company Information
- 8.14.2 BML Business Overview
- 8.14.3 BML Laboratory-Developed Testing Service Revenue and Gross Margin (2021-2026)
- 8.14.4 BML Laboratory-Developed Testing Service Product Portfolio
- 8.14.5 BML Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst